Crossmark

Early clearance of serum HE4 and CA125 in predicting platinum sensitivity and prognosis in epithelial ovarian cancer

Published Online: 2021-01-04

Published Print: 2021-12

Authors

Rong, Yan http://orcid.org/0000-0003-4219-0167
Li, Li
Funding

Funding for this research was provided by:

Key Laboratory of Early Prevention & Treatment of Regional High-Incidence-Tumor, Ministry of Education

Innovation Project of Guangxi Graduate Education (No. YCBZ2020051)
License Information

Text and Data Mining valid from 2021-01-04

Version of Record valid from 2021-01-04
More Information

Article History

Received: 17 July 2020

Accepted: 21 December 2020

First Online: 4 January 2021

Ethics approval and consent to participate

: The study was reviewed by the Ethics Committee of Guangxi Medical University Cancer Hospital, and was considered that the research met the requirements of medical ethics (Number: LW2020080). The written informed consents of all treatments and examinations were obtained from patients or their families.

: Not applicable.

: The authors declare that they have no competing of interests.

Document is current